These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7823767)

  • 1. Antagonism of nicotine's action by cocaine analogs.
    Lerner-Marmarosh N; Carroll FI; Abood LG
    Life Sci; 1995; 56(3):PL67-70. PubMed ID: 7823767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
    Damaj MI; Slemmer JE; Carroll FI; Martin BR
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of the antagonism of nicotine's central effects by mecamylamine and pempidine.
    Martin TJ; Suchocki J; May EL; Martin BR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):45-51. PubMed ID: 2366189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]benzylpempidine, a new radioligand for probing a putative channel site on nicotinic cholinergic receptors.
    Wang DX; Sheu SS; Sharma VK; Rubin L; Journet M; Kende AS; Abood LG
    Life Sci; 1997; 60(15):1271-7. PubMed ID: 9096244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues.
    Banerjee S; Punzi JS; Kreilick K; Abood LG
    Biochem Pharmacol; 1990 Nov; 40(9):2105-10. PubMed ID: 2242037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites and mechanisms for nicotine's action in the brain.
    Abood LG; Reynolds DT; Booth H; Bidlack JM
    Neurosci Biobehav Rev; 1981; 5(4):479-86. PubMed ID: 6119664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatum.
    Izenwasser S; Jacocks HM; Rosenberger JG; Cox BM
    J Neurochem; 1991 Feb; 56(2):603-10. PubMed ID: 1988558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of brain nicotinic receptors by chronic agonist infusion.
    Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
    J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 125I-Labeled alpha-bungarotoxin and [3H]quinuclidinylbenzilate binding to rat brain membranes. Effects of physical, chemical and enzymatic treatments.
    Salvaterra PM
    Biochim Biophys Acta; 1980 Sep; 601(1):78-91. PubMed ID: 6773577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging.
    Meltzer PC; Liang AY; Brownell AL; Elmaleh DR; Madras BK
    J Med Chem; 1993 Apr; 36(7):855-62. PubMed ID: 8464040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of carbamate and other esters: agonists and antagonists to nicotine.
    Abood LG; Shahid Salles K; Maiti A
    Pharmacol Biochem Behav; 1988 Jun; 30(2):403-8. PubMed ID: 3174772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2-exo- and 2-endo-mecamylamine analogues. Structure-activity relationships for nicotinic antagonism in the central nervous system.
    Suchocki JA; May EL; Martin TJ; George C; Martin BR
    J Med Chem; 1991 Mar; 34(3):1003-10. PubMed ID: 2002445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous material in brain inhibiting [3H]nicotine and [3H]acetylcholine binding.
    Sershen H; Reith ME; Hashim A; Lajtha A
    J Neurosci Res; 1984; 12(4):563-9. PubMed ID: 6512887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs.
    Schwartz RD; Kellar KJ
    J Neurochem; 1985 Aug; 45(2):427-33. PubMed ID: 4009168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
    Costa LG; Murphy SD
    J Pharmacol Exp Ther; 1983 Aug; 226(2):392-7. PubMed ID: 6875853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.